Sylvia Richard-Bildstein

Sylvia Richard-Bildstein is an accomplished medicinal chemist with extensive experience in high throughput medicinal chemistry and project leadership. Currently serving as Associate Director and Team Leader at Idorsia Pharmaceuticals Ltd since June 2017, Richard-Bildstein manages a team focused on library design, reaction optimization, and the implementation of new enabling technologies. Prior to this role, Richard-Bildstein was Director and Team Leader at Actelion (now Janssen Pulmonary Hypertension) for nearly 18 years, where significant contributions included establishing a flow chemistry platform and leading various high throughput projects. Richard-Bildstein's professional journey encompasses roles at Synthelabo Biomoleculaire, Hoechst Marion Roussel, and Marion Merrell Dow, alongside a robust academic background culminating in a PhD in Medicinal Chemistry from Université Louis Pasteur.